REPLAY
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.
REPLAY
Industry:
Biotechnology Therapeutics
Founded:
2021-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.replay.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
55 M USD
Current Advisors List
Investors List
OMX Ventures
OMX Ventures investment in Seed Round - Replay
Kohlberg Kravis Roberts
Kohlberg Kravis Roberts investment in Seed Round - Replay
Artis Ventures (AV)
Artis Ventures (AV) investment in Seed Round - Replay
Salt Ventures
Salt Ventures investment in Seed Round - Replay
DeciBio Ventures
DeciBio Ventures investment in Seed Round - Replay
Lansdowne Partners
Lansdowne Partners investment in Seed Round - Replay
Axial VC
Axial VC investment in Seed Round - Replay
Artis Ventures (AV)
Artis Ventures (AV) investment in Seed Round - Replay
Official Site Inspections
http://www.replay.bio Semrush global rank: 4.44 M Semrush visits lastest month: 2.48 K
- Host name: 104.21.73.89
- IP address: 104.21.73.89
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Replay"
Replay - Crunchbase Company Profile & Funding
Organization. Replay . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Replay is a genome …See details»
Replay
Replay Holdings, Inc. 5555 Oberlin Drive, Suite 120 San Diego, CA 92121 [email protected]See details»
Team - Replay
Replay Holdings, Inc. 5555 Oberlin Drive, Suite 120 San Diego, CA 92121 [email protected]See details»
Replay - LinkedIn
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.See details»
Replay Holdings Company Profile | Management and Employees …
[email protected]: 6: first: [email protected]: 7: last: [email protected]: Your Questions, Our Answers Get Free Access to Replay Holdings Contacts Info. What is Replay Holdings …See details»
Replay (Drug Discovery) - PitchBook
Jul 7, 2020 Replay (Drug Discovery) General Information Description. Developer of a hypoimmunogenic iPSC therapeutic platform designed for gene therapy and genome engineering. The company offers an assembled toolkit of disruptive …See details»
Replay Holdings - Overview, News & Similar companies - ZoomInfo
May 22, 2023 Replay Holdings contact info: Phone number: (858) 859-2610 Website: replay.bio What does Replay Holdings do? Replay is a company that operates in the biotechnology …See details»
Replay Company Profile - Office Locations, Competitors, Revenue …
Replay is a company developing an enzyme writing product platform for reprogramming biology by writing and delivering big DNA constructs. It offers genomic products, synthetic gene …See details»
Replay Overview | SignalHire Company Profile
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA. ... Organization Website. …See details»
Replay Launches with $55 Million Seed to Reprogram Biology by …
Jul 25, 2022 Replay Bio . Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA. KKR and OMX Ventures lead $55 million seed funding round. …See details»
Replay launches to reprogram biology by writing and delivering …
Jul 25, 2022 Replay’s genomic medicine toolkit comprises several synergistic technology platforms, including synHSV – a high payload capacity HSV vector able to deliver up to 30 …See details»
Replay Launches with $55 Million Seed to Reprogram Biology by …
Jul 25, 2022 KKR is investing in Replay through KKR Health Care Strategic Growth Fund II, a $4.0 billion fund focused on investing in high-growth health care companies. Ends. About …See details»
Replay Launches with $55 Million Seed to Reprogram Biology
Jul 25, 2022 [email protected]. Consilium Strategic Communications – Media relations Amber Fennell/Tracy Cheung/Jessica Hodgson [email protected]. KKR Alastair …See details»
Replay establishes distinguished Scientific Advisory Board
Oct 17, 2022 Replay establishes distinguished Scientific Advisory Board of genomic medicine and cell therapy experts San Diego, California and London, UK, October...See details»
Replay Bio (company) - Nordic 9
Replay Bio; Replay Bio (private company) replay.bio . See something wrong or missing? Let us know. Offices: London, San Diego. Industry: Biotech Health services. Business model: B2B. …See details»
Management | Team - Replay
Replay Holdings, Inc. 5555 Oberlin Drive, Suite 120 San Diego, CA 92121 [email protected]See details»
Replay receives $1.5 million grant for its hypoimmunogenic
Nov 28, 2022 Replay developing uCell™, its universal, off-the-shelf, genomically rewritten, renewable cell source hypoimmunogenic technology, with support from the Bill & Melinda …See details»
Replay Bio news - the latest biotech news from Labiotech.eu
Jul 24, 2023 Replay Bio has announced the launch of Eudora, an HSV (herpes simplex virus) gene therapy company targeting genetic retinal diseases. It is the first of Replay’s product …See details»
Platform | Replay
Replay Holdings, Inc. 5555 Oberlin Drive, Suite 120 San Diego, CA 92121 [email protected]See details»
Founders | Team - Replay
Replay has assembled a team of industry leaders, entrepreneurs, scientists, and physicians dedicated to authoring the future of genomic medicine. All Company FoundersSee details»